| Index | — | P/E | 11.08 | EPS (ttm) | 5.32 | Insider Own | 4.16% | Shs Outstand | 16.90M | Perf Week | 0.80% |
| Market Cap | 995.74M | Forward P/E | 10.31 | EPS next Y | 5.72 | Insider Trans | 0.00% | Shs Float | 16.46M | Perf Month | 3.04% |
| Enterprise Value | 1.09B | PEG | 1.50 | EPS next Q | 1.39 | Short Float | 4.61% | Perf Quarter | -1.41% | ||
| Income | 91.00M | P/S | 2.87 | EPS this Y | 21.03% | Short Ratio | 8.17 | Perf Half Y | 22.59% | ||
| Sales | 347.00M | P/B | 1.38 | EPS next Y | 6.67% | ROA | 1.28% | Short Interest | 758.36K | Perf YTD | 35.85% |
| Book/sh | 42.67 | P/C | 0.64 | EPS next 5Y | 7.37% | ROE | 12.66% | 52W High | 60.59 -2.74% | Perf Year | 51.92% |
| Cash/sh | 92.68 | P/FCF | 9.76 | EPS past 3/5Y | -2.71% -0.56% | ROIC | 5.97% | 52W Low | 37.78 55.98% | Perf 3Y | 109.27% |
| Dividend Est. | 1.68 (2.85%) | EV/EBITDA | 8.80 | Sales past 3/5Y | 20.64% 12.46% | Gross Margin | 69.14% | Volatility | 2.73% 2.27% | Perf 5Y | 20.68% |
| Dividend TTM | 1.68 (2.85%) | EV/Sales | 3.15 | EPS Y/Y TTM | 51.57% | Oper. Margin | 26.33% | ATR (14) | 1.46 | Perf 10Y | 91.02% |
| Dividend Ex-Date | Oct 15, 2026 | Quick Ratio | 0.26 | Sales Y/Y TTM | 0.29% | Profit Margin | 26.00% | RSI (14) | 59.69 | Recom | 2.33 |
| Dividend Gr. 3/5Y | 1.64% 4.94% | Current Ratio | 0.26 | EPS Q/Q | 8.06% | SMA20 | 3.58% | Beta | 0.57 | Target Price | 58.00 |
| Payout | 31.59% | Debt/Eq | 0.52 | Sales Q/Q | 1.08% | SMA50 | 3.38% | Rel Volume | 0.95 | Prev Close | 57.34 |
| Employees | 683 | LT Debt/Eq | 0.09 | Earnings | Jan 26 | SMA200 | 12.73% | Avg Volume | 88.24K | Price | 58.93 |
| IPO Date | Oct 08, 1997 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.15% -1.67% | Net Debt/EBITDA | -9.60 | Volume | 84,212 | Change | 2.77% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-28-26 | Reiterated | National Bank | $55 → $58 | |
| Sep-15-26 | Initiated | Hovde Group | Market Perform | $60 |
| Jul-30-26 | Reiterated | National Bank | $50 → $55 | |
| Jul-01-26 | Reiterated | Raymond James | Outperform | $56 → $58 |
| Apr-29-26 | Reiterated | Raymond James | Outperform | $54 → $56 |
| Apr-29-26 | Reiterated | National Bank | $47 → $50 | |
| Feb-05-26 | Reiterated | Stephens | Overweight | $53 |
| Jan-28-26 | Reiterated | National Bank | $45 → $47 | |
| Oct-29-25 | Reiterated | National Bank | $44 → $45 | |
| Aug-06-25 | Upgrade | Stephens & Co. | Equal Weight → Overweight |
Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers in the United States. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system. Its loan products include non-owner-occupied commercial real estate loans; owner-occupied commercial real estate loans; commercial loans; residential real estate loans, including one- to four-family residences; and consumer and home equity loans. In addition, the company provides brokerage and insurance services through its financial offerings consisting of college, retirement, estate planning, mutual funds, strategic asset management accounts, and variable and fixed annuities. Further, it offers a range of fiduciary and asset management, wealth management, investment management and advisory, financial planning, and trustee services. Camden National Corporation was founded in 1875 and is headquartered in Camden, Maine.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 347 | 367 | 290 | 250 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 107 | 137 | 118 | 94 | — | — | — | — | — | |
| Gross Profit | 240 | 231 | 172 | 156 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 101 | 60 | 64 | 60 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 47 | 89 | 43 | 42 | — | — | — | — | — | |
| Operating Income | 91 | 82 | 65 | 54 | — | — | — | — | — | |
| Interest Expense | 105 | 117 | 117 | 94 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 129 | 114 | 117 | 94 | — | — | — | — | — | |
| Net Income Before Taxes | 114 | 79 | 65 | 54 | — | — | — | — | — | |
| Income Taxes | 24 | 13 | 12 | 10 | — | — | — | — | — | |
| Consolidated Net Income | 91 | 65 | 53 | 43 | — | — | — | — | — | |
| Net Income From Continuing Operations | 91 | 65 | 53 | 43 | — | — | — | — | — | |
| Net Income | 91 | 65 | 53 | 43 | — | — | — | — | — | |
| EPS (Recurring) | 5.34 | 3.85 | 3.63 | 2.98 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.34 | 3.85 | 3.63 | 2.98 | — | — | — | — | — | |
| EPS (Diluted) | 5.32 | 3.84 | 3.62 | 2.97 | — | — | — | — | — | |
| EBITDA | 124 | 93 | 69 | 58 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 11.08 | 11.30 | 11.81 | 12.67 | — | — | — | — | — | |
| Price To Sales Ratio | 2.89 | 2.01 | 2.21 | 2.26 | — | — | — | — | — | |
| Gross Margin | 69.16 | 62.94 | 59.31 | 62.40 | — | — | — | — | — | |
| Operating Margin | 26.22 | 22.34 | 22.41 | 21.60 | — | — | — | — | — | |
| Net Margin | 26.22 | 17.71 | 18.28 | 17.20 | — | — | — | — | — | |
| Shares Outstanding | 17 | 17 | 15 | 15 | — | — | — | — | — | |
| Market Capitalization | 1,002 | 737 | 641 | 564 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Maxwell Raina | Director | May 28 '25 | Buy | 40.09 | 103 | 4,113 | 563 | May 30 |
| Merrill Robert D | Director | Feb 04 '25 | Sale | 43.94 | 500 | 21,970 | 9,615 | Feb 06 |